181 related articles for article (PubMed ID: 35856645)
1.
Serda M; Malarz K; Korzuch J; Szubka M; Zubko M; Musioł R
ACS Biomater Sci Eng; 2022 Aug; 8(8):3450-3462. PubMed ID: 35856645
[TBL] [Abstract][Full Text] [Related]
2. Identification and Biological Evaluation of a Water-Soluble Fullerene Nanomaterial as BTK Kinase Inhibitor.
Malarz K; Korzuch J; Marforio TD; Balin K; Calvaresi M; Mrozek-Wilczkiewicz A; Musiol R; Serda M
Int J Nanomedicine; 2023; 18():1709-1724. PubMed ID: 37025922
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and properties of novel water-soluble fullerene-glycine derivatives as new materials for cancer therapy.
Jiang G; Yin F; Duan J; Li G
J Mater Sci Mater Med; 2015 Jan; 26(1):5348. PubMed ID: 25578702
[TBL] [Abstract][Full Text] [Related]
4. Interactions between modified fullerenes and proteins in cancer nanotechnology.
Serda M; Korzuch J; Dreszer D; Krzykawska-Serda M; Musioł R
Drug Discov Today; 2023 Sep; 28(9):103704. PubMed ID: 37453461
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography (PET) guided glioblastoma targeting by a fullerene-based nanoplatform with fast renal clearance.
Peng Y; Yang D; Lu W; Hu X; Hong H; Cai T
Acta Biomater; 2017 Oct; 61():193-203. PubMed ID: 28801268
[TBL] [Abstract][Full Text] [Related]
6. Uncovering nanotoxicity of a water-soluble and red-fluorescent [70]fullerene nanomaterial.
Dreszer D; Szewczyk G; Szubka M; Maroń AM; Urbisz AZ; Małota K; Sznajder J; Rost-Roszkowska M; Musioł R; Serda M
Sci Total Environ; 2023 Jun; 879():163052. PubMed ID: 36963679
[TBL] [Abstract][Full Text] [Related]
7. In vivo, in vitro and in silico anticancer investigation of fullerene C
Beyaz S; Aslan A; Gok O; Uslu H; Agca CA; Ozercan IH
Life Sci; 2022 Feb; 291():120281. PubMed ID: 34982963
[TBL] [Abstract][Full Text] [Related]
8. Water-soluble fullerene-based nanostructures with promising antiviral and myogenic activity.
Kraevaya OA; Novikov AV; Shestakov AF; Ershova ES; Savinova EA; Kameneva LV; Veiko NN; Schols D; Balzarini J; Kostyuk SV; Troshin PA
Chem Commun (Camb); 2020 Sep; 56(70):10203-10206. PubMed ID: 32748905
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of anticancer activity in cells of novel stoichiometric pegylated fullerene-doxorubicin conjugates.
Magoulas GE; Bantzi M; Messari D; Voulgari E; Gialeli C; Barbouri D; Giannis A; Karamanos NK; Papaioannou D; Avgoustakis K
Pharm Res; 2015 May; 32(5):1676-93. PubMed ID: 25380982
[TBL] [Abstract][Full Text] [Related]
10. Carbon nanomaterials: Biologically active fullerene derivatives.
Bogdanović G; Djordjević A
Srp Arh Celok Lek; 2016; 144(3-4):222-31. PubMed ID: 27483572
[TBL] [Abstract][Full Text] [Related]
11. An Update Report on the Biosafety and Potential Toxicity of Fullerene-Based Nanomaterials toward Aquatic Animals.
Malhotra N; Audira G; Castillo AL; Siregar P; Ruallo JMS; Roldan MJ; Chen JR; Lee JS; Ger TR; Hsiao CD
Oxid Med Cell Longev; 2021; 2021():7995223. PubMed ID: 34336114
[TBL] [Abstract][Full Text] [Related]
12. Fullerene as a doxorubicin nanotransporter for targeted breast cancer therapy: Capillary electrophoresis analysis.
Kepinska M; Kizek R; Milnerowicz H
Electrophoresis; 2018 Sep; 39(18):2370-2379. PubMed ID: 29931716
[TBL] [Abstract][Full Text] [Related]
13. Fullerenes as an Effective Amyloid Fibrils Disaggregating Nanomaterial.
Siposova K; Petrenko VI; Ivankov OI; Musatov A; Bulavin LA; Avdeev MV; Kyzyma OA
ACS Appl Mater Interfaces; 2020 Jul; 12(29):32410-32419. PubMed ID: 32598133
[TBL] [Abstract][Full Text] [Related]
14. Refluxed Esterification of Fullerene-Conjugated P25 TiO
Lee KC; Chen YL; Wang CC; Huang JH; Cho EC
ACS Appl Mater Interfaces; 2019 Jan; 11(1):311-319. PubMed ID: 30540433
[TBL] [Abstract][Full Text] [Related]
15. Fullerene-conjugated doxorubicin in cells.
Liu JH; Cao L; Luo PG; Yang ST; Lu F; Wang H; Meziani MJ; Haque SA; Liu Y; Lacher S; Sun YP
ACS Appl Mater Interfaces; 2010 May; 2(5):1384-9. PubMed ID: 20420365
[TBL] [Abstract][Full Text] [Related]
16. Anticoronavirus Activity of Water-Soluble Pristine C
Hurmach V; Platonov M; Prylutska S; Klestova Z; Cherepanov V; Prylutskyy Y; Ritter U
Adv Exp Med Biol; 2021; 1352():159-172. PubMed ID: 35132600
[TBL] [Abstract][Full Text] [Related]
17. Closed network growth of fullerenes.
Dunk PW; Kaiser NK; Hendrickson CL; Quinn JP; Ewels CP; Nakanishi Y; Sasaki Y; Shinohara H; Marshall AG; Kroto HW
Nat Commun; 2012 May; 3():855. PubMed ID: 22617295
[TBL] [Abstract][Full Text] [Related]
18. Buckysomes: fullerene-based nanocarriers for hydrophobic molecule delivery.
Partha R; Mitchell LR; Lyon JL; Joshi PP; Conyers JL
ACS Nano; 2008 Sep; 2(9):1950-8. PubMed ID: 19206436
[TBL] [Abstract][Full Text] [Related]
19. Fullerene nanomaterials potentiate hair growth.
Zhou Z; Lenk R; Dellinger A; MacFarland D; Kumar K; Wilson SR; Kepley CL
Nanomedicine; 2009 Jun; 5(2):202-7. PubMed ID: 19223242
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of inflammatory arthritis using fullerene nanomaterials.
Dellinger AL; Cunin P; Lee D; Kung AL; Brooks DB; Zhou Z; Nigrovic PA; Kepley CL
PLoS One; 2015; 10(4):e0126290. PubMed ID: 25879437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
